Check-Cap Ltd. Stock News

CheckCap Ltd. (CHEK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean

ShockWave Medical, CheckCap and Biosig Technologies are part of The Zacks top Analyst Blog.

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares climbed 121.3% to close at $1.46 on Wednesday after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ul

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-r

Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float. NewAge, In

Gainers NewAge, Inc. (NASDAQ: NBEV) rose 54.4% to $0.3220. IN8bio, Inc. (NASDAQ: INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2

Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on Monday. The company recently reported an exclusive compression technology p

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Minerva Neuroscien

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) shares rose 34.5% t

During the last session, Check-Cap Ltd. (NASDAQ:CHEK)’s traded shares were 1.47 million, with the beta value of the company hitting 0.46. At the end of the trading day, the stock’s price was $0.39, reflecting an intraday gain of 2.55% or $0.01. The 52-week high for the CHEK share is $4.49, that puts it down -1051.28 … Is Check-Cap Ltd. (NASDAQ: CHEK) Still A Loss Stock Despite Being Down -42.20% YTD? Read More »

Check-Cap Ltd. (NASDAQ:CHEK) with the stream of -1.42% also noticed, India Team, Inc. (NYSE:TISI) encountered a rapid change of 3.51% in the last hour of Monday’s trading session. Check-Cap Ltd. … The post Stock Runner: Check-Cap Ltd. (NASDAQ:CHEK), Team, Inc. (NYSE:TISI) appeared first on Stocks Equity .

Check-Cap Ltd. (NASDAQ:CHEK)s traded shares stood at 0.54 million during the last session, with the companys beta value hitting 0.45. At the close of trading, the stocks price was $0.61, to imply a decrease of -4.60% or -$0.03 in intraday trading. The CHEK shares 52-week high remains $4.49, putting it -636.07% down since that peak After Jumping 2.12% During The Past Week, Should You Still Buy Check-Cap Ltd. (NASDAQ: CHEK)? Read More »

Check-Cap (CHEK) plans to start the U.S. pivotal study for its C-Scan cancer screening test after the FDA approved its amended Investigational Device Exemption ((IDE)) application,